TP53 and rheumatoid arthritis: Elevated expression of miR-34a in BM-MSC-derived Evs activated the p53 signaling pathway by inhibiting cyclin I (CCNI) expression, which in turn inhibited FLS proliferation and promotes apoptosis, and thus had a positive effect on alleviating the inflammatory state of RA.